Kalaris Therapeutics Inc (KLRS)

$6.70 +0.18 (2.76%)
Market Cap 32.88M
Revenue (ttm) 0.00
Net Income (ttm) -58.77M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 13,900
Avg Vol 30,036
Day's Range N/A - N/A
Shares Out 5.04M
Stochastic %K 29%
Beta 0.68
Analysts Strong Sell
Price Target $21.00

Latest News on KLRS

Kalaris Expands Board of Directors Appointing Leone Patterson as Chair of Audit Committee

Apr 4, 2025, 8:00 AM EDT - 21 days ago

Kalaris Expands Board of Directors Appointing Leone Patterson as Chair of Audit Committee

Kalaris Announces Closing of Merger with AlloVir

Mar 18, 2025, 4:21 PM EDT - 5 weeks ago

Kalaris Announces Closing of Merger with AlloVir

ALVR